The COVID-19 pandemic has undoubtedly disrupted nearly every aspect of global society, making the emergence of several vaccines a welcome development. The United States, along with the European Union, has prioritized the purchasing and distribution of vaccines since early December 2020.
Read MoreSince the beginning of the COVID-19 pandemic, developing countries faced long delays obtaining access to vaccines due to vaccine nationalism and hoarding by rich countries. To fill the gap, India has emerged as a ‘vaccine superpower’ and source of hope to poorer countries, which are unable to access vaccines due to their high cost and unavailability. India is offering governments in developing nations both the locally-manufactured British AstraZeneca vaccine and its own home-grown vaccine, Covaxin.
Read More
Canada is defending its decision to accept coronavirus vaccines from COVAX, a program developed to help low- and middle- income countries with the vaccination process. According to The Washington Post, Deputy Prime Minister Chrystia Freeland stated that the Canadian government “will never apologize” for doing what they can to vaccinate Canadians alongside the rest of the world.
Read More
On January 30, the European Union reversed its decision to restrict COVID-19 vaccine exports into Britain through Northern Ireland, according to the New York Times.
Read More
Much as it has dominated headlines throughout 2020, the COVID-19 pandemic was the most highlighted issue at the annual United Nations General Assembly, which celebrated its 75th anniversary this year.
Read More
COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, and the World Health Organization (WHO), who is working with vaccine manufacturers across the world. COVAX’s goal is to acquire and deliver two billion doses of approved vaccines by the end of 2021.
Read More